Head - Pharma Portfolio - Formulation Strategy - US & EU Market

Head - Pharma Portfolio - Formulation Strategy - US & EU Market

- Strategic Direction & Planning: Define and execute the overarching portfolio strategy, translating market trends, healthcare policies, and patient needs into actionable growth priorities.

- Pipeline Prioritization: Lead the evaluation and prioritization of R&D projects (from early-stage discovery to late-stage trials) based on therapeutic value, commercial potential, and risk.

- Asset Management: Manage the lifecycle of existing and new products, ensuring clinical development and commercial readiness are aligned with global business goals.

- Business Development Support: Provide strategic input for in-licensing opportunities, mergers, and acquisitions (M&A) to bridge portfolio gaps.

- Governance & Performance: Establish KPIs and governance frameworks to monitor portfolio health, track resource allocation, and ensure projects remain within budget and on timeline.

- Stakeholder Leadership: Act as a thought partner to senior executives and lead cross-functional teams across R&D, Medical Affairs, Market Access, and Finance